Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia: Final appraisal document

DRAFT guidance supports use (separate tablets/fixed-dose combination) for primary hypercholesterolaemia (heterozygous familial & non-familial) or mixed dyslipidaemia as adjunct to diet in adults if statins contraindicated/not tolerated & ezetimibe does not control LDL-C enough.

Source:

National Institute for Health and Care Excellence